Encompass Health
395 hedge funds and large institutions have $5.21B invested in Encompass Health in 2022 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 147 increasing their positions, 132 reducing their positions, and 51 closing their positions.
25% more call options, than puts
Call options by funds: $16.9M | Put options by funds: $13.4M
11% more repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 132
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
10% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 51
1.52% less ownership
Funds ownership: 119.08% → 117.56% (-1.5%)
3% less funds holding
Funds holding: 407 → 395 (-12)
21% less capital invested
Capital invested by funds: $6.57B → $5.21B (-$1.36B)
Top Buyers
Top Sellers
EHC Hedge Fund Activity: Q2 2022 in Review
395 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q2 2022, worth a combined $5.21B — down 21% from $6.57B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of EHC and 46 opened new positions — a net loss of 5 holders — while 132 trimmed existing stakes and 147 added.
The largest buyer was Invesco, adding an estimated $78.6M. The largest seller was Canyon Capital Advisors, cutting an estimated $52.7M.
- 395 institutional investors held Encompass Health (EHC) as of Q2 2022, down from 407 in Q1 2022.
- Funds reported $5.21B of Encompass Health stock for Q2 2022, down 21% quarter-over-quarter.
- 46 funds opened new Encompass Health positions in Q2 2022 and 51 closed out, a net change of -5 holders.
- The largest Encompass Health buyer in Q2 2022 was Invesco, an estimated $78.6M added.
- The largest Encompass Health seller in Q2 2022 was Canyon Capital Advisors, an estimated $52.7M sold.
Based on aggregated 13F filings for Q2 2022.